Thursday, October 19, 2023 6:05:39 PM
October 19, 2023 at 04:26 pm EDT
Share
The Amwell Converge™ platform will enable DHA healthcare teams to deliver connected and seamless in-person, virtual, and automated care delivery for the Military Health System
Amwell® (NYSE: AMWL), a leader in hybrid healthcare enablement, together with Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, was recently awarded a next-generation contract to provide a hybrid care technology platform designed to power the “Digital First” transformation of the Military Health System (MHS).
Under this task order, the Leidos Partnership for Defense Health (LPDH) will deliver Amwell Converge™, a comprehensive hybrid care enablement platform designed to power the full continuum of care using digital, virtual and automated modalities, and replace the Military Health System (MHS) Video Connect solution. It will start at five initial sites followed by a phased enterprise roll-out. Also included in the contract are a broad spectrum of Amwell automated care programs that have a proven track record of helping deliver better health outcomes, including multiple behavioral health and integrated core telehealth solutions. If all options are exercised, the task order has a 22-month period of performance with a total value of up to $180 million to the LPDH.
“Through our world class platform Converge, Amwell is already enabling hybrid care across the commercial marketplace. With this agreement, we are pleased to offer our unique capabilities and help improve access to quality care for the MHS community of users. We are grateful for their service, and honored to have been chosen to join Leidos in supporting the Department of Defense as it seeks to adopt and extend the benefits of hybrid care to the Military Health System,” said Ido Schoenberg, M.D., chairman and CEO of Amwell.
The DHA’s Digital First initiative brings new capabilities and enablement to MHS GENESIS, an advanced electronic health record (EHR) and healthcare system solution that supports military and Veteran healthcare initiatives. The Converge platform has deep integration assets and a simple yet powerful user experience that enables efficient and quality hybrid care delivery. The platform is already embedded into existing clinical workflows that care teams rely on, including those within the core EHR that powers MHS GENESIS. Together, Amwell and LPDH will enable the DHA to leverage the benefits of hybrid care, improve access to primary and behavioral health care, and ultimately improve outcomes for the MHS community.
The DHA supports national security and ensures our nation’s military teams are ready to deploy. Seeking to leverage innovation and best practices from the commercial sector, the DHA conducted a thorough evaluation of the Amwell solution.
“We are delighted that the demonstrated scalability, flexibility, and comprehensiveness of the Amwell Converge platform, as evaluated by DHA, uniquely qualifies Amwell to support the DHA’s Digital First strategies and readiness mission. We are dedicated to supporting this program with the best that Amwell offers for many years to come,” said Dr. Schoenberg.
“Digital First addresses DHA’s goal of better outcomes, new processes, innovation and increased standardization based on evidence,” said Jason McCarthy, Leidos senior vice president, Military and Veterans Health Solutions. “As part of our overall MHS GENESIS effort to enhance patient experience, we, along with Amwell, are looking forward to providing near real-time, self-service support and hybrid care options for our customer and those whom they serve.”
Digital First will support the entire MHS community of users, which includes 9.6 million active-duty service members, family members, retirees, and health professionals across the continuum of care. Through integrated platform solutions, Amwell and Leidos will help reduce burdens on care teams, improve the mental health and wellness of beneficiaries, help reduce healthcare costs and optimize the effective utilization of DHA's clinical resources across their global enterprise.
About Amwell
Amwell provides a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. The company offers a single, comprehensive platform designed to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the hybrid care of more than 55 health plans, which collectively represent more than 90 million covered lives, and many of the nation’s largest health systems, representing over 2,000 hospitals, have access to Amwell solutions. For more information, please visit https://business.amwell.com/.
©2023 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.
This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.
Recent AMWL News
- Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference • GlobeNewswire Inc. • 05/16/2024 08:05:00 PM
- AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2024 • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- Amwell Releases 2024 Corporate Responsibility Report • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Amwell to Participate in Upcoming Investor Conference • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Amwell® to Report First Quarter 2024 Operating Results May 1 • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- Amwell Receives Continued Listing Standard Notice From NYSE • GlobeNewswire Inc. • 04/04/2024 08:05:00 PM
- Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024 • GlobeNewswire Inc. • 03/06/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:37:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:37:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:36:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:36:16 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/01/2024 10:12:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:48:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:47:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:46:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:45:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:07:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:05:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:03:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:01:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:40:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:39:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:38:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:37:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:36:50 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM